The system's decision-makers must consider the long-term implications for PBS sustainability of continually imposing change. The industry can help by understanding its interlocutor and developing a credible case for policy stability.
A misguided response disconnected from its own history and reality
March 18, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
AusBiotech urges adoption national life sciences strategy as global competition intensifies
February 2, 2026 - - Australian Biotech -
Cyclopharm delivers record revenue as US emerges as growth engine
February 2, 2026 - - Australian Biotech -
Sandoz adds to vision care options with the listing of biosimilar aflibercept
February 2, 2026 - - Latest News -
PYC’s capital raise marks one of the largest biotech fundraisings in Australian market history
February 2, 2026 - - Australian Biotech -
Genetic Signatures appoints seasoned life sciences executive as CEO
February 2, 2026 - - Australian Biotech -
EMA decision clears regulatory path for Argenica’s lead stroke drug in Europe
February 2, 2026 - - Australian Biotech -
Recce Pharmaceuticals deepens US partnership to advance burn wound treatment
February 2, 2026 - - Australian Biotech

